Source: Annual Congress 2002 - Biological disease markers in airways and parenchymal lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Nakajima, H. Nakamura, H. Tateno, N. Minematsu, S. Fujishima, K. Yamaguchi (Tokyo, Japan). Elevation of plasma cystatin C levels in patients with COPD. Eur Respir J 2002; 20: Suppl. 38, 3604

Member's Comments

No comment yet.

Related content which might interest you: COPD patients with more severe GOLD stages have higher serum cystatin C levels Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Magnesium levels in erythrocytes and plasma in patients with exacerbated COPD Source: Eur Respir J 2001; 18: Suppl. 33, 429s Year: 2001 Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study Source: International Congress 2017 – Markers of COPD progression Year: 2017 C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008 Asthmatics with high levels of serum surfactant protein D have more severe disease Source: Eur Respir J 2016; 47:1864-1867 Year: 2016